Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Raw Materials (2016 - 2025)

Historic Raw Materials for Iridex (IRIX) over the last 15 years, with Q3 2025 value amounting to $3.9 million.

  • Iridex's Raw Materials fell 1662.7% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 1662.7%. This contributed to the annual value of $4.2 million for FY2024, which is 1989.41% down from last year.
  • Iridex's Raw Materials amounted to $3.9 million in Q3 2025, which was down 1662.7% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Iridex's Raw Materials registered a high of $6.5 million during Q2 2023, and its lowest value of $2.2 million during Q1 2021.
  • Over the past 5 years, Iridex's median Raw Materials value was $4.5 million (recorded in 2022), while the average stood at $4.6 million.
  • Per our database at Business Quant, Iridex's Raw Materials skyrocketed by 7607.33% in 2022 and then crashed by 2380.81% in 2024.
  • Iridex's Raw Materials (Quarter) stood at $3.8 million in 2021, then skyrocketed by 51.92% to $5.8 million in 2022, then fell by 9.14% to $5.3 million in 2023, then decreased by 19.89% to $4.2 million in 2024, then fell by 8.97% to $3.9 million in 2025.
  • Its Raw Materials stands at $3.9 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.8 million for Q1 2025.